PHYSIOLOGICALLY-BASED TOXICOKINETIC MODELING OF 1,3-BUTADIENE LUNG METABOLISM IN MICE BECOMES MORE IMPORTANT AT LOW-DOSES

被引:23
作者
EVELO, CTA
OOSTENDORP, JGM
TENBERGE, WF
BORM, PJA
机构
[1] DSM,CORP DIV SAFETY & ENVIRONM,HEERLEN,NETHERLANDS
[2] UNIV LIMBURG,DEPT HLTH RISK ANAL & TOXICOL,6200 MD MAASTRICHT,NETHERLANDS
关键词
1,3-BUTADIENE; COMPUTER SIMULATION; PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING; PHYSIOLOGICALLY BASED TOXICOKINETIC MODELING; RISK EVALUATION; TOXICOKINETICS;
D O I
10.2307/3431586
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
This paper describes a physiologically based toxicokinetic model for 1,3-butadiene uptake, distribution, and metabolic clearance in mice. Model parameters for metabolic activity were estimated from the correspondence between computer simulation studies and experimental results as published in the literature. The parameterized model was validated with independent literature data. With the resulting model, the relative importance of lung metabolism as compared to metabolism in the liver increased with decreasing ambient air concentrations. This was due to saturation of metabolism in the alveolar area of the lung, which occurred in the simulations at ambient air concentrations well below current threshold limit values. At higher air concentration, liver metabolism became relatively more important. The tendency toward increased importance of lung metabolism at low doses indicates the necessity of careful extrapolation of in vive results to low doses. Moreover, this trend may also contribute to species difference in susceptibility to the carcinogenic activity of butadiene.
引用
收藏
页码:496 / 502
页数:7
相关论文
共 39 条
[31]  
PATERSON S, 1989, BRIT J IND MED, V46, P321
[32]   ANALYSIS OF LOW-MOLECULAR-WEIGHT HYDROCARBONS INCLUDING 1,3-BUTADIENE IN ENGINE EXHAUST-GASES USING AN ALUMINUM-OXIDE POROUS-LAYER OPEN-TUBULAR FUSED-SILICA COLUMN [J].
PELZ, N ;
DEMPSTER, NM ;
SHORE, PR .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1990, 28 (05) :230-235
[33]   A PHYSIOLOGICALLY BASED DESCRIPTION OF THE INHALATION PHARMACOKINETICS OF STYRENE IN RATS AND HUMANS [J].
RAMSEY, JC ;
ANDERSEN, ME .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1984, 73 (01) :159-175
[34]  
SCHMIDT U, 1985, ARCH TOXICOL, V57, P222, DOI 10.1007/BF00324781
[35]  
TRAVIS CC, 1988, CARCINOGEN RISK ASSE, V3
[36]  
VANDUUREN BL, 1963, J NATL CANCER I, V31, P41
[37]  
1986, IARC MONOGRAPHS EVAL, V39, P155
[38]  
1991, FED REGISTER, V56, P28548
[39]  
1990, RA590 DUTCH MIN SOC